Evidence map›Paper›PMID 35585965›Full record

ArticleMolecular genetics and metabolism reports2022

Development of minimally invasive

Abrar Turki, Sylvia Stockler, Sandra Sirrs, Ramona Salvarinova, Gloria Ho, Jennifer Branov, Annie Rosen-Heath, Taryn Bosdet, Rajavel Elango

Open access · goldAbstract read
In one paragraph

Article in Molecular genetics and metabolism reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Abrar TurkiBC Children's Hospital Research Institute, Vancouver, British Columbia, Canada.
Sylvia StocklerBC Children's Hospital Research Institute, Vancouver, British Columbia, Canada.
Sandra SirrsDepartment of Medicine, Division of Endocrinology, University of British Columbia, Vancouver, British Columbia, Canada.
Ramona SalvarinovaBC Children's Hospital Research Institute, Vancouver, British Columbia, Canada.
Gloria HoDivision of Biochemical Genetics, BC Children's Hospital, Vancouver, British Columbia, Canada.
Jennifer BranovVancouver Costal Health, Adult Metabolic Diseases Clinic, Vancouver, British Columbia, Canada.
Annie Rosen-HeathVancouver Costal Health, Adult Metabolic Diseases Clinic, Vancouver, British Columbia, Canada.
Taryn BosdetVancouver Costal Health, Adult Metabolic Diseases Clinic, Vancouver, British Columbia, Canada.
Rajavel ElangoBC Children's Hospital Research Institute, Vancouver, British Columbia, Canada.
University of British Columbia · CAVancouver Coastal Health · CABC Children's Hospital · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Glycogen storage disease type Ia (GSD Ia) is an autosomal recessive disorder caused by deficiency of glucose-6-phosphatase (G6Pase), resulting in fasting hypoglycemia. Dietary treatment with provision of uncooked cornstarch (UCCS) or a novel modified cornstarch ( Objectives: Our objectives were: 1) establishing the use of a minimally invasive Design: Results: Conclusions:

Indexed as

13C-GBT, 13C-glucose breath test13C-glucoseAPE, atom percent excessAUC, area under the curveBIA, bioelectrical impedance analysisBMI, body mass indexBreath testCGM, continuous glucose monitorCmax, maximum peak enrichment in 13CO2 oxidationCREU, clinical research and evaluation unitF13CO2, rate of glucose oxidationFCO2, CO2 production rate using indirect calorimetryFFM, fat free massFM, fat massG6Pase, glucose-6-phosphataseG6P, glucose-6-phosphateGlucose-6-phosphataseGlycogen storage disease type IaGlycosade®GSD Ia, glycogen storage disease type IaGSD I, glycogen storage disease type IHSCT, hematopoietic stem cell transplantationOGTT, oral glucose tolerance testPKU, phenylketonuriaREE, resting energy expendituretmax, time to reach maximum 13CO2 oxidationUCCS, uncooked cornstarchUncooked cornstarchVCO2, rate of carbon dioxide production

Identifiers

PMID35585965
PMCPMC9109185
OpenAlexW4280516007

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.